Prosecution Insights
Prosecution Insights
Technology areas: Chemistry & Materials • Medical Devices & Mechanical Engineering
5 pending office actions • 3 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
SIO2 Medical Products Inc. manages 5 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are distributed across 5 distinct examiners and 3 distinct art units. This distribution shows that the company's patent applications are being reviewed by a diverse group of examiners, which may result in different prosecution experiences for each of the 5 pending office actions. The involvement of 3 distinct art units suggests the portfolio covers several technical sub-specialties.
HALL, DEANNA K is the busiest examiner for this portfolio, currently overseeing 1 pending office action. Because there are 5 distinct examiners for 5 pending office actions, the workload is distributed among the assigned staff. For practitioners, this means that no single examiner's habits will dominate the prosecution of the entire portfolio. However, the concentration within 3 distinct art units implies that some examiners likely share the same supervisory and policy environment, which could provide some level of consistency across the 5 pending matters.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (80%) |
| Multi-statute (no §101) | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HALL, DEANNA K | 1 | 75.7% | +15.7% |
| ARBLE, JESSICA R | 1 | 66.3% | +25.4% |
| ROMANOWSKI, MICHAEL C | 1 | 53.2% | +62.4% |
| CHATRATHI, ARJUNA P | 1 | 62.3% | +22.0% |
| PEO, KARA M | 1 | 42.5% | +37.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18018868 | METHOD AND PACKAGE FOR REDUCING THE DEGRADATION OF A DRUG AND/OR EXCIPIENT, E.G. POLYSORBATE STABILIZER, IN A PHARMACEUTICAL PRODUCT | PEO, KARA M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18552708 | ATOMIC LAYER DEPOSITION COATED PHARMACEUTICAL PACKAGING AND IMPROVED SYRINGES AND VIALS, E.G. FOR LYOPHILIZED/COLD-CHAIN DRUGS/VACCINES | CHATRATHI, ARJUNA P | 44d overdue |
| 18560187 | Drug Primary Package Having Integrated RFID Tag | ARBLE, JESSICA R | 36d overdue |
| 18843492 | IMPROVED SYRINGE AND GASKET SYSTEMS | HALL, DEANNA K | — |
| 18498734 | STERILIZABLE PHARMACEUTICAL PACKAGE FOR OPHTHALMIC FORMULATIONS | ROMANOWSKI, MICHAEL C | — |
| 18018868 | METHOD AND PACKAGE FOR REDUCING THE DEGRADATION OF A DRUG AND/OR EXCIPIENT, E.G. POLYSORBATE STABILIZER, IN A PHARMACEUTICAL PRODUCT | PEO, KARA M | — |
| Art Unit | Apps |
|---|---|
| 3781 | 2 |
| 1782 | 1 |
| 1777 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18843492 | IMPROVED SYRINGE AND GASKET SYSTEMS | HALL, DEANNA K | — | §103 | Non-Final OA | — | Pending | Sep 03, 2024 |
| 18560187 | Drug Primary Package Having Integrated RFID Tag | ARBLE, JESSICA R | 3781 | §103 | Final Rejection | 36d overdue | Pending | Nov 10, 2023 |
| 18498734 | STERILIZABLE PHARMACEUTICAL PACKAGE FOR OPHTHALMIC FORMULATIONS | ROMANOWSKI, MICHAEL C | 1782 | §103 | Final Rejection | — | Pending | Oct 31, 2023 |
| 18552708 | ATOMIC LAYER DEPOSITION COATED PHARMACEUTICAL PACKAGING AND IMPROVED SYRINGES AND VIALS, E.G. FOR LYOPHILIZED/COLD-CHAIN DRUGS/VACCINES | CHATRATHI, ARJUNA P | 3781 | §103 | Final Rejection | 44d overdue | Pending | Sep 27, 2023 |
| 18018868 | METHOD AND PACKAGE FOR REDUCING THE DEGRADATION OF A DRUG AND/OR EXCIPIENT, E.G. POLYSORBATE STABILIZER, IN A PHARMACEUTICAL PRODUCT | PEO, KARA M | 1777 | §102§112 | Non-Final OA | — | Pending | Jan 30, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial